SLOW-K Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Slow-k, and what generic alternatives are available?
Slow-k is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in SLOW-K is potassium chloride. There is one drug master file entry for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Slow-k
A generic version of SLOW-K was approved as potassium chloride by ACTAVIS LABS FL INC on April 10th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SLOW-K?
- What are the global sales for SLOW-K?
- What is Average Wholesale Price for SLOW-K?
Summary for SLOW-K
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 250 |
| Patent Applications: | 3,613 |
| DailyMed Link: | SLOW-K at DailyMed |
US Patents and Regulatory Information for SLOW-K
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SLOW-K | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 017476-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
